Fig. 10From: Bioinformatics analysis of prognostic value and prospective pathway signal of miR-30a in ovarian cancerThe expression of ESR1, MAPK10, Tp53, YKT, NSF and the prognosis of patients with ovarian cancer were analyzed. According to the median expression level, patients with ovarian cancer were divided into high expression group and low expression groupBack to article page